Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study
Crossref DOI link: https://doi.org/10.1186/s40644-016-0063-7
Published Online: 2016-03-16
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Ji Hyun
Lee, Ho Yun
Ahn, Myung-Ju
Park, Keunchil
Ahn, Jin Seok
Sun, Jong-Mu
Lee, Kyung Soo
Funding for this research was provided by:
the Korean Foundation for Cancer Research (KFCR-CB-2011-02-02)